Chick Chorioallantoic Membrane Model and Precision Cancer Therapy

Chick Chorioallantoic Membrane Model and Precision Cancer Therapy, Volume 46 in The Enzymes series, highlights new advances in the field, with this new volume presenting interesting chapters on the history of CAM model development, an overview of various CAM-based cancer models, the chick embryo chorioallantoic membrane as an in vivo experimental model to study multiple myelomak, bioluminescent CAM models for screening drugs against pancreatic cancer, X-ray sensitizer screen, patient derived tumor model for esophageal cancer, renal cancer and metastasis, nanoparticle characterization and tumor targeting, and patient derived tumor model for human nasopharyngeal carcinoma.

1. Recent excitements in the study of the CAM assay Fuyuhiko Tamanoi 2. The history of the development of chick embryo tumor xenograft models Yoshio Endo 3. The chick embryo chorioallantoic membrane as an in vivo experimental model to study multiple myeloma Domenico Ribatti and Roberto Tamma 4. Various CAM tumor models Aoi Komatsu, Yuya Higashi and Kotaro Matsumoto 5. Mouse- and patient-derived CAM xenografts for studying metastatic renal cell carcinoma Moe Ishihara, Junhui Hu, Anthony Wong, Celine Cano-Ruiz and Lily Wu 6. Patient-derived tumor models for human nasopharyngeal carcinoma Xiaoying Zhou, Weilin Zhao, Yufeng Chen and Zhe Zhang 7. Patient-derived tumor models of esophageal cancer Tomoki Saito, Shinya Ohashi, Ayaka Mizumoto and Manabu Muto 8. In vivo drug screening method of radiosensitizers using tumor-bearing chick embryo Yoshihiro Uto, Chiaki Abe, Mana Futawaka, Hisatsugu Yamada, Masahide Tominaga and Yoshio Endo 9. Nanoparticles characterization using the CAM assay Soontaree (Grace) Intasa-ard and Albane Birault